Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Resveratrol for iron overload and inflammation in beta-thalassemia major
IRCT20250809066797N2Phase 2Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of resveratrol in beta thalassemia, sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Change in iron overload parameters and Change in inflammatory markers. Started Nov 2025; status: completed.
02
Drugs
resveratrol
03
Conditions
beta thalassemia
Beyond the preview
Go deeper on IRCT20250809066797N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250809066797N2.